Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency SUR Library | Available |
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Contents:; 1.The King of Diseases?: An Essay on the Special Attention Paid to Cancer Patients and How It Came About; 2 One in Four Dies of Cancer. Questions About the Epidemiology of Malignant Tumours; 3 HPV Vaccination in Bangladesh: Ethical Views; 4 Using Human Tumor Cell Lines in Cancer Research…
c.1 BC Cancer Agency VAN Library | Available |
Table of Contents:; Introduction: patient-centered health : who, what, and how? -- Patient-centered care or patient-centered health? -- Respecting and promoting patient autonomy in research, end-of-life care, and chronic illness care -- Escaping the autonomy vs objectivity trap by re-personalizing …
Contents:; 1. Reflections on the Past -- 2. Government, Law, and Ethics -- 3. Tort Law and Reform -- 4. Criminal Aspects of Health Care -- 5. Contracts -- 6. Civil Procedure and Trial Practice-- 7. Corporate Structure and Legal Issues -- 8. Medical Staff Organization and Physician Liability -- 9. N…
c.1 BC Cancer Agency VAN Library | Available |
Brain; Breast; Gastro-intestinal; Genito-urinary; Gynecologic; Head and neck; Hematologic; IND; Lung; Melanoma; Sarcoma; Symptom control
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | On Loan, due Wednesday, November 14, 2018 |
This report focuses on investment in research focused on cancer risk and prevention over a three-year period. Research is critiical to our understanding of cancer risk and effective cancer prevention strategies. The investment in cancer risk and prevention at $122.3M represented 11% of the overal…
c.1 BC Cancer Agency VAN Library | Available |
Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions; Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions; Guidelines on the use of intravenous immune globulin for hematologic conditions; Guidelines…
c.1 BC Cancer Agency VIC Library | Available |